Indefinite Delivery Contract 36E79720D0022
Award Date
5/21/20
Last Date to Order
5/25/25
Federal Agency
National Acquisition Center
Awardee
Mylan Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract, valued up to $10,813,880, to Radha Pharmaceuticals Inc., a minority-owned small business manufacturer, to provide Carbidopa/Levodopa sustained-action tablets. The contract has a base period of one year from May 23, 2025 to May 22, 2026, with four one-year option periods. The contract aims to secure an uninterrupted supply of these pharmaceutical products for the VA, Department...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency of the U.S. federal government, to Avkare LLC, a pharmaceutical and medical supply company. The contract has a ceiling value of $21,739,614.15 and a period of performance from June 21, 2021 to June 20, 2026, with an initial one-year base period and four one-year option periods. The contract is for the delivery of Carbidopa/Levodopa tablets in various sizes to support the healthcare...
The federal contract IDV award to Mylan Pharmaceuticals Inc. is a single-award Indefinite Delivery Contract (IDC) issued by the Department of Veterans Affairs (VA) National Acquisition Center. The contract, valued at up to $9,549,893.15 over its 5-year period of performance, enables Mylan to supply clozapine tablets to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). This contract is an extension of Mylan's ongoing role as a prime vendor of specialty...
The federal contract IDV award is for the supply of Thioridazine HCl tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) through the VA's Pharmaceutical Prime Vendor program. The single-award indefinite delivery contract was issued by the VA National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods, with a ceiling value of $267,666.40 and a period of...
The Department of Veterans Affairs (VA) has awarded Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies, an IDV Federal Supply Schedule contract (36F79723D0194) valued at over $16.3 million. This multiple-award contract covers the procurement of drugs, pharmaceuticals, and hematology-related products through September 2028. Under this IDV, the VA Veterans Integrated Service Network 12 has issued firm fixed-price delivery orders for Acorda's Levodopa 42mg...
Mylan Pharmaceuticals Inc. is providing pharmaceutical products to the Department of Veterans Affairs National Acquisition Center under a single-award Indefinite Delivery Contract. The contract has a potential value of $92.9 million and a period of performance through August 2024. Under the terms of the contract, Mylan will supply divalproex sodium tablets to meet the medication needs of veterans served by VA, DoD, Bureau of Prisons and Indian Health Service medical facilities nationwide. As the...
The Indefinite Delivery Contract (IDC) SPE2D222D0147 was awarded by the Defense Logistics Agency (DLA) to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The single-award IDC has a total ceiling value of $10,967,220.00 and a period of performance running through September 13, 2027. Under this contract, Mylan will provide the DLA, Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service with a variety of...
This federal contract indefinite delivery vehicle (IDV) is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Merz Pharmaceuticals, LLC, a foreign-owned for-profit organization. The contract is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has a ceiling value of $95,726,580.00 with a period of performance through September 14, 2025. A specific delivery order issued under this IDV has a ceiling value of $653,990.40 and...
The federal contract IDV is a single-award Indefinite Delivery Contract awarded by the National Acquisition Center of the Department of Veterans Affairs (VA) to The Harvard Drug Group, L.L.C. dba Major Pharmaceuticals. The contract is for the procurement of Lurasidone Hydrochloride (HCL) Tablets in various strengths, with a base ordering period of 12/10/2024 to 12/09/2025 and four one-year option periods, for a total ceiling value of $10,056,938.10. The contract will serve the VA, Department...
The National Acquisition Center of the U.S. Department of Veterans Affairs (VA) awarded a single-award Indefinite Delivery Contract (IDC) to Mylan Pharmaceuticals Inc. to provide Loperamide Hydrochloride (HCL) capsules. The contract has a potential value of $8,960,715.85 and a period of performance from July 30, 2020 to July 29, 2025, with four one-year option periods. The contracted products will be distributed through the VA's and Department of Defense's (DoD) respective Pharmaceutical Prime...